Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Receivables (2016 - 2025)

Utah Medical Products has reported Change in Receivables over the past 16 years, most recently at -$92000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$92000.0 for Q4 2025, down 117.39% from a year ago — trailing twelve months through Dec 2025 was $5000.0 (down 99.4% YoY), and the annual figure for FY2025 was $5000.0, down 99.4%.
  • Change in Receivables for Q4 2025 was -$92000.0 at Utah Medical Products, down from $506000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for UTMD hit a ceiling of $2.1 million in Q4 2023 and a floor of -$1.8 million in Q1 2023.
  • Median Change in Receivables over the past 5 years was $40000.0 (2021), compared with a mean of $44800.0.
  • Peak annual rise in Change in Receivables hit 5522.22% in 2025, while the deepest fall reached 578.31% in 2025.
  • Utah Medical Products' Change in Receivables stood at -$760000.0 in 2021, then plummeted by 37.5% to -$1.0 million in 2022, then soared by 304.11% to $2.1 million in 2023, then plummeted by 75.2% to $529000.0 in 2024, then crashed by 117.39% to -$92000.0 in 2025.
  • The last three reported values for Change in Receivables were -$92000.0 (Q4 2025), $506000.0 (Q3 2025), and -$397000.0 (Q2 2025) per Business Quant data.